These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32042114)

  • 1. BMP9 signaling promotes the normalization of tumor blood vessels.
    Viallard C; Audiger C; Popovic N; Akla N; Lanthier K; Legault-Navarrete I; Melichar H; Costantino S; Lesage S; Larrivée B
    Oncogene; 2020 Apr; 39(14):2996-3014. PubMed ID: 32042114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability.
    Akla N; Viallard C; Popovic N; Lora Gil C; Sapieha P; Larrivée B
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1821-1836. PubMed ID: 29880487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMP9/ALK1 inhibits neovascularization in mouse models of age-related macular degeneration.
    Ntumba K; Akla N; Oh SP; Eichmann A; Larrivée B
    Oncotarget; 2016 Aug; 7(35):55957-55969. PubMed ID: 27517154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells.
    Araki M; Hisamitsu T; Kinugasa-Katayama Y; Tanaka T; Harada Y; Nakao S; Hanada S; Ishii S; Fujita M; Kawamura T; Saito Y; Nishiyama K; Watanabe Y; Nakagawa O
    Angiogenesis; 2018 May; 21(2):415-423. PubMed ID: 29478089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation.
    Alsina-Sanchís E; García-Ibáñez Y; Figueiredo AM; Riera-Domingo C; Figueras A; Matias-Guiu X; Casanovas O; Botella LM; Pujana MA; Riera-Mestre A; Graupera M; Viñals F
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1216-1229. PubMed ID: 29449337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.
    Ouarné M; Bouvard C; Boneva G; Mallet C; Ribeiro J; Desroches-Castan A; Soleilhac E; Tillet E; Peyruchaud O; Bailly S
    J Exp Clin Cancer Res; 2018 Aug; 37(1):209. PubMed ID: 30165893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling.
    Ricard N; Ciais D; Levet S; Subileau M; Mallet C; Zimmers TA; Lee SJ; Bidart M; Feige JJ; Bailly S
    Blood; 2012 Jun; 119(25):6162-71. PubMed ID: 22566602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SEMA3G regulates BMP9 inhibition of VEGF-mediated migration and network formation in pulmonary endothelial cells.
    Mirza SL; Upton PD; Hodgson J; Gräf S; Morrell NW; Dunmore BJ
    Vascul Pharmacol; 2024 Jun; 155():107381. PubMed ID: 38795838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMP9 attenuates occurrence of venous malformation by maintaining endothelial quiescence and strengthening vessel walls via SMAD1/5/ID1/α-SMA pathway.
    Li Y; Shang Q; Li P; Yang Z; Yang J; Shi J; Ge S; Wang Y; Fan X; Jia R
    J Mol Cell Cardiol; 2020 Oct; 147():92-107. PubMed ID: 32730768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis.
    Cunha SI; Pardali E; Thorikay M; Anderberg C; Hawinkels L; Goumans MJ; Seehra J; Heldin CH; ten Dijke P; Pietras K
    J Exp Med; 2010 Jan; 207(1):85-100. PubMed ID: 20065063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMP9 Induces Cord Blood-Derived Endothelial Progenitor Cell Differentiation and Ischemic Neovascularization via ALK1.
    Kim J; Kim M; Jeong Y; Lee WB; Park H; Kwon JY; Kim YM; Hwang D; Kwon YG
    Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):2020-31. PubMed ID: 26229139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Context-dependent signaling defines roles of BMP9 and BMP10 in embryonic and postnatal development.
    Chen H; Brady Ridgway J; Sai T; Lai J; Warming S; Chen H; Roose-Girma M; Zhang G; Shou W; Yan M
    Proc Natl Acad Sci U S A; 2013 Jul; 110(29):11887-92. PubMed ID: 23812757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of selective anti-BMP9 treatment on tumor cells and tumor angiogenesis.
    Brand V; Lehmann C; Umkehrer C; Bissinger S; Thier M; de Wouters M; Raemsch R; Jucknischke U; Haas A; Breuer S; Birzele F; Racek T; Reis M; Lorenzon E; Herting F; Stürzl M; Lorenz S; Kienast Y
    Mol Oncol; 2016 Dec; 10(10):1603-1620. PubMed ID: 28949445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMP9-ID1 Signaling Activates HIF-1α and VEGFA Expression to Promote Tumor Angiogenesis in Hepatocellular Carcinoma.
    Chen H; Nio K; Tang H; Yamashita T; Okada H; Li Y; Doan PTB; Li R; Lv J; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting.
    van Meeteren LA; Thorikay M; Bergqvist S; Pardali E; Stampino CG; Hu-Lowe D; Goumans MJ; ten Dijke P
    J Biol Chem; 2012 May; 287(22):18551-61. PubMed ID: 22493445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells.
    Luo J; Tang M; Huang J; He BC; Gao JL; Chen L; Zuo GW; Zhang W; Luo Q; Shi Q; Zhang BQ; Bi Y; Luo X; Jiang W; Su Y; Shen J; Kim SH; Huang E; Gao Y; Zhou JZ; Yang K; Luu HH; Pan X; Haydon RC; Deng ZL; He TC
    J Biol Chem; 2010 Sep; 285(38):29588-98. PubMed ID: 20628059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of ALK1-mediated signalling by BMP9/BMP10 and their prodomain-bound forms.
    Salmon RM; Guo J; Wood JH; Tong Z; Beech JS; Lawera A; Yu M; Grainger DJ; Reckless J; Morrell NW; Li W
    Nat Commun; 2020 Apr; 11(1):1621. PubMed ID: 32238803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formation.
    Levet S; Ciais D; Merdzhanova G; Mallet C; Zimmers TA; Lee SJ; Navarro FP; Texier I; Feige JJ; Bailly S; Vittet D
    Blood; 2013 Jul; 122(4):598-607. PubMed ID: 23741013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling.
    Eleftheriou NM; Sjölund J; Bocci M; Cortez E; Lee SJ; Cunha SI; Pietras K
    Oncotarget; 2016 Dec; 7(51):84314-84325. PubMed ID: 27741515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMP9 regulates endoglin-dependent chemokine responses in endothelial cells.
    Young K; Conley B; Romero D; Tweedie E; O'Neill C; Pinz I; Brogan L; Lindner V; Liaw L; Vary CP
    Blood; 2012 Nov; 120(20):4263-73. PubMed ID: 23018639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.